Ioana Hone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioana hone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioana Hone Today - Breaking & Trending Today

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , William Wood , Jill Howe , David Thelander , Al Kingsley , Joe Pantginis , Mayank Mamtani , Brian Culley , Jack Allen , Dana Red Foundation , California Institute For Regenerative Medicine , Global Head Of Ophthalmology Product Development , Lineage Cell Therapeutics Inc , Lineage Cell Therapeutics , Call Transcript May , Cell Therapeutics , Lineage Cell Therapeutics First Quarter , Ioana Hone , Investor Relations , Chief Executive Officer , Chief Financial , Opregen Phase , Vice President , Global Head , Ophthalmology Product Development , California Institute ,

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2023 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2023 Earnings Call Transcript August 10, 2023 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.04. Operator: Welcome to the Lineage Cell Therapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call […] ....

United Kingdom , United States , Brian Culley , Jill Howe , Cancer Research United Kingdom , University Of Michigan , David Tepper , Investment Strategy , Crowded States , Lineage Cell Therapeutics , Brian Culley , Ioana Hone , Clinical Benefit , Clinical Benefits , Forward Looking Statements ,

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2023 Earnings Call Transcript

Operator: Welcome to the Lineage Cell Therapeutics First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. ....

La Jolla , United States , United Kingdom , Michael Okunewitch , Gary Hogge , Joe Pantginis , Jill Howe , Brian Culley , Mayank Mamtani , Jack Allen , Matej Kastelic Shutterstock , Kristen Kluska , Doheny Image Research Lab , Maxim Group , Reeve Foundation , University Of Michigan , Dana Reeve Foundation , California Institute For Regenerative Medicine , Cancer Research United Kingdom , Lineage Cell Therapeutics Inc , Lineage Cell Therapeutics , Call Transcript May , Cell Therapeutics , Lineage Cell Therapeutics First Quarter , Ioana Hone , Investor Relations ,

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode. ....

United States , William Wood , Roche Genentech , Jack Allen , Gary Hogge , Brian Culley , Jill Howe , Mayank Mamtani , Software Stocks To Invest , California Institute For Regenerative Medicine , Cancer Research Uk We , University Of Michigan , Cancer Research , Lineage Cell Therapeutics Inc , Health Photo , National Cancer Institute On Unsplash , Cincinnati Eye Institute , Lineage Cell Therapeutics , Call Transcript March , Lineage Cell Therapeutics Fourth Quarter , Full Year , Ioana Hone , Investor Relations , Chief Executive Officer , Chief Financial Officer , Senior Vice President ,

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2022 Earnings Call Transcript

LCTX earnings call for the period ending June 30, 2022. ....

United States , Gary Hogge , Brian Culley , Cancer Research , Cord Outcomes Partnership , Lineage Cell Therapeutics Inc , California Institute Of Regenerative Medicine , American Spinal Injury Association , Lineage Cell Therapeutics , Ioana Hone , Executive Officer , Interim Chief Financial , California Institute , Regenerative Medicine , Spinal Cord Outcomes Partnership Endeavor ,